Sigyn Therapeutics Announces Reverse Stock Split

January 30, 2024

SAN DIEGO, CA, Jan. 30, 2024 (GLOBE NEWSWIRE) — via NewMediaWire — Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB:SIGY), a development-stage medical technology company, today announced that a 1-for-40 reverse split of its common stock will be implemented tomorrow, January 31, 2024. As a result, the Company’s common stock will trade on a post-split basis at the beginning of the trading day on January 31st under its existing trading symbol “SIGY.” The CUSIP number for the common stock following the reverse stock split will be 82674U205.

Read more at globenewswire.com

Related news for (SIGY)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.